Anne Hume to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Anne Hume has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.278
-
Li L, Jesdale BM, Hume A, Gambassi G, Goldberg RJ, Lapane KL. Pharmacotherapy Use in Older Patients With Heart Failure and Reduced Ejection Fraction After a Skilled Nursing Facility Stay. J Card Fail. 2017 Dec; 23(12):843-851.
Score: 0.130
-
Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst. 2008 Sep 03; 100(17):1223-32.
Score: 0.070
-
Lapane KL, Hume AL, Barbour MM, Lipsitz LA. Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors on health outcomes of very old patients with heart failure? J Am Geriatr Soc. 2002 Jul; 50(7):1198-204.
Score: 0.045
-
Li L, Jesdale BM, Hume A, Gambassi G, Goldberg RJ, Lapane KL. Who are they? Patients with heart failure in American skilled nursing facilities. J Cardiol. 2018 04; 71(4):428-434.
Score: 0.033